|
NUP93 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.681200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.257000E-01 |
| Normal-vs-Stage2 |
9.704600E-01 |
| Normal-vs-Stage3 |
1.272410E-01 |
| Normal-vs-Stage4 |
3.170800E-01 |
| Stage1-vs-Stage2 |
6.001800E-01 |
| Stage1-vs-Stage3 |
8.930400E-02 |
| Stage1-vs-Stage4 |
1.532200E-01 |
| Stage2-vs-Stage3 |
1.226620E-01 |
| Stage2-vs-Stage4 |
3.003000E-01 |
| Stage3-vs-Stage4 |
4.118500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.184000E-01 |
| Normal-vs-AfricanAmerican |
8.694600E-01 |
| Normal-vs-Asian |
5.181200E-01 |
| Caucasian-vs-AfricanAmerican |
1.501030E-01 |
| Caucasian-vs-Asian |
8.148800E-01 |
| AfricanAmerican-vs-Asian |
4.277000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.143600E-01 |
| Normal-vs-Female |
4.524200E-02 |
| Male-vs-Female |
4.918400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.849000E-01 |
| Normal-vs-Extreme_Weight |
5.011200E-01 |
| Normal-vs-Obese |
1.427580E-01 |
| Normal-vs-Extreme_Obese |
8.367800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.960950E-01 |
| Normal_Weight-vs-Obese |
1.740000E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.456400E-01 |
| Extreme_Weight-vs-Obese |
1.760040E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.577400E-01 |
| Obese-vs-Extreme_Obese |
2.189200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.495400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.211800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.823400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.942000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.076800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.850200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.955800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.714400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.118900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.887800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.595400E-01 |
| Normal-VS-Type2 PRCC |
9.303600E-01 |
| Normal-VS-KIRP CIMP |
1.641380E-01 |
| Normal-VS-Unclassified PRCC |
4.278200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.849800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.013000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.804000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.224200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.902300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.249800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.228800E-01 |
| Normal-vs-N1 |
2.674600E-01 |
| Normal-vs-N2 |
7.493800E-01 |
| N0-vs-N1 |
9.834300E-02 |
| N0-vs-N2 |
8.304600E-01 |
| N1-vs-N2 |
3.601600E-01 |
|
|
